71 related articles for article (PubMed ID: 21533369)
1. The progestin ORG2058 but not retinoic acid stimulates BRCA1 mRNA expression in MCF-7 human breast cancer cells.
Caligo M; Bellachene A; Cipollini G; Bevilacqua G; Castronovo V
Int J Oncol; 1997 Feb; 10(2):253-6. PubMed ID: 21533369
[TBL] [Abstract][Full Text] [Related]
2. Expression and regulation of retinoic acid receptors in human breast cancer cells.
Roman SD; Clarke CL; Hall RE; Alexander IE; Sutherland RL
Cancer Res; 1992 Apr; 52(8):2236-42. PubMed ID: 1313739
[TBL] [Abstract][Full Text] [Related]
3. Hormone-dependent regulation of BRCA1 in human breast cancer cells.
Gudas JM; Nguyen H; Li T; Cowan KH
Cancer Res; 1995 Oct; 55(20):4561-5. PubMed ID: 7553629
[TBL] [Abstract][Full Text] [Related]
4. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
5. Retinoid antagonism of estrogen-responsive transforming growth factor alpha and pS2 gene expression in breast carcinoma cells.
Fontana JA; Nervi C; Shao ZM; Jetten AM
Cancer Res; 1992 Jul; 52(14):3938-45. PubMed ID: 1319834
[TBL] [Abstract][Full Text] [Related]
6. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
7. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
[TBL] [Abstract][Full Text] [Related]
8. Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues.
Rajan JV; Marquis ST; Gardner HP; Chodosh LA
Dev Biol; 1997 Apr; 184(2):385-401. PubMed ID: 9133444
[TBL] [Abstract][Full Text] [Related]
9. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
[TBL] [Abstract][Full Text] [Related]
10. The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.
Ma Y; Katiyar P; Jones LP; Fan S; Zhang Y; Furth PA; Rosen EM
Mol Endocrinol; 2006 Jan; 20(1):14-34. PubMed ID: 16109739
[TBL] [Abstract][Full Text] [Related]
11. Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines.
Castronovo V; Taraboletti G; Liotta LA; Sobel ME
J Natl Cancer Inst; 1989 May; 81(10):781-8. PubMed ID: 2523976
[TBL] [Abstract][Full Text] [Related]
12. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of Frizzled-10 (FZD10) by beta-estradiol in MCF-7 cells and by retinoic acid in NT2 cells.
Saitoh T; Mine T; Katoh M
Int J Oncol; 2002 Jan; 20(1):117-20. PubMed ID: 11743650
[TBL] [Abstract][Full Text] [Related]
14. Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.
Lu M; Mira-y-Lopez R; Nakajo S; Nakaya K; Jing Y
Oncogene; 2005 Jun; 24(27):4362-9. PubMed ID: 15870697
[TBL] [Abstract][Full Text] [Related]
15. Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells.
Berkenstam A; Glaumann H; Martin M; Gustafsson JA; Norstedt G
Mol Endocrinol; 1989 Jan; 3(1):22-8. PubMed ID: 2915647
[TBL] [Abstract][Full Text] [Related]
16. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
17. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes.
Loman N; Johannsson O; Bendahl PO; Borg A; Fernö M; Olsson H
Cancer; 1998 Jul; 83(2):310-9. PubMed ID: 9669814
[TBL] [Abstract][Full Text] [Related]
18. Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines.
Read LD; Snider CE; Miller JS; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1988 Mar; 2(3):263-71. PubMed ID: 3398853
[TBL] [Abstract][Full Text] [Related]
19. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
20. Estradiol induction of retinoic acid receptors in human breast cancer cells.
Roman SD; Ormandy CJ; Manning DL; Blamey RW; Nicholson RI; Sutherland RL; Clarke CL
Cancer Res; 1993 Dec; 53(24):5940-5. PubMed ID: 8261407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
